Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Modern Chinese Medicine Group Co. Ltd. ( (HK:1643) ) has issued an update.
Modern Chinese Medicine Group Co., Ltd. has announced a further delay in sending a shareholder circular related to a major transaction involving the acquisition of sale shares, originally expected by 30 April 2026. The company now expects to dispatch the circular by 30 June 2026, citing the need for additional time to finalise pro forma financial information for the enlarged group.
To accommodate the delay, the company has applied to the Hong Kong Stock Exchange for a waiver from strict compliance with the listing rule governing the timing of circular dispatch. As the waiver has not yet been granted, the company has indicated it will issue further announcements as appropriate, signaling ongoing regulatory engagement and a potential shift in the timetable for completing the acquisition.
More about Modern Chinese Medicine Group Co. Ltd.
Modern Chinese Medicine Group Co., Ltd. is a Hong Kong-listed company incorporated in the Cayman Islands and engaged in the modern Chinese medicine sector. The group operates through subsidiaries and is governed by a board comprising executive and independent non-executive directors, reflecting a typical corporate governance structure for a listed pharmaceutical or healthcare enterprise.
Average Trading Volume: 3,181,308
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.12B
Learn more about 1643 stock on TipRanks’ Stock Analysis page.